More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$28.78B
EPS
-13.05
P/E ratio
--
Price to sales
0.16
Dividend yield
--
Beta
1.062428
Previous close
$59.15
Today's open
$60.07
Day's range
$57.93 - $60.76
52 week range
$25.08 - $62.21
show more
CEO
Sarah M. London
Employees
60500
Headquarters
St. Louis, MO
Exchange
New York Stock Exchange
Shares outstanding
493797000
Issue type
Common Stock
Healthcare
Medical Service Plans
U.S. Health Insurers Raise EPS Estimates After Strong Q1'26, Higher Medicare Rates
The first quarter proved to be a boon for many major US managed care insurers, as earnings results exceeded consensus estimates, leading to rises in stock prices and higher full-year earnings estimates. The Centers for Medicare & Medicaid Services released higher-than-expected 2027 rates for Medicare Advantage plans that are aimed at seniors, assuaging some investor concerns.
Seeking Alpha • May 20, 2026

Easing medical costs a positive for health insurers, but real test lies ahead, analysts say
U.S. health insurers' strong first-quarter results signaled more stable medical costs after prolonged pressure, but Wall Street analysts want to see another similar quarter before they are convinced.
Reuters • May 13, 2026

Superior HealthPlan Awards $100,000 in Grants to 10 Community-based Organizations in Texas
The funding is made available through an annual program that addresses barriers to healthcare. AUSTIN, Texas, May 12, 2026 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE: CNC), has announced the 2026 recipients of its annual grant program.
PRNewsWire • May 12, 2026

Health Insurers Performing Better But There's Potential Trouble Ahead
Health insurance companies including UnitedHealthcare, CVS Health's Aetna, Centene and Blue Cross and Blue Shield plans owned by Elevance Health are seeing lower costs from patients submitting claims.
Forbes • May 10, 2026

Has Centene (CNC) Outpaced Other Medical Stocks This Year?
Here is how Centene (CNC) and Cellectar Biosciences, Inc. (CLRB) have performed compared to their sector so far this year.
Zacks Investment Research • May 7, 2026

New Strong Buy Stocks for May 7th
CSTM, CNC, TEAM, WDC and COLM have been added to the Zacks Rank #1 (Strong Buy) List on May 7, 2026.
Zacks Investment Research • May 7, 2026

Best Growth Stocks to Buy for May 7th
CNC, WOOF and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 7, 2026.
Zacks Investment Research • May 7, 2026

Best Value Stocks to Buy for May 7th
CNC, SLDE and UVE made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 7, 2026.
Zacks Investment Research • May 7, 2026

Here's Why Centene (CNC) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • May 5, 2026

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how
Don Lair writes about options income, dividend strategy, and the kind of boring-but-durable investing that actually funds retirement.
24/7 Wall Street • May 4, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Centene Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.